677 reports of this reaction
2.1% of all MECLIZINE HCL 25 MG reports
#10 most reported adverse reaction
ASTHENIA is the #10 most commonly reported adverse reaction for MECLIZINE HCL 25 MG, manufactured by Advanced Rx LLC. There are 677 FDA adverse event reports linking MECLIZINE HCL 25 MG to ASTHENIA. This represents approximately 2.1% of all 32,440 adverse event reports for this drug.
Patients taking MECLIZINE HCL 25 MG who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ASTHENIA is a less commonly reported adverse event for MECLIZINE HCL 25 MG, but still significant enough to appear in the safety profile.
In addition to asthenia, the following adverse reactions have been reported for MECLIZINE HCL 25 MG:
The following drugs have also been linked to asthenia in FDA adverse event reports:
ASTHENIA has been reported as an adverse event in 677 FDA reports for MECLIZINE HCL 25 MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
ASTHENIA accounts for approximately 2.1% of all adverse event reports for MECLIZINE HCL 25 MG, making it a notable side effect.
If you experience asthenia while taking MECLIZINE HCL 25 MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.